The South-Wales-based company is an emerging player in the field of regenerative medicine, offering solutions for wound care management that maximise a patient's natural healing response and so help decrease the closing time of chronic and complex wounds.
Corryn Biotechnologies has raised €661k across 1 funding round from 1 investor, most recently a Seed round in Sep 2024. Based in South Wales, UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-09-24 | Seed | €661k |
| British Design Fund |
| View deal → |
